ARN-4079

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameARN-4079
Drug Alias NameARN-4079
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase ITK/TSK inhibitorsTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrien Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesArrien Pharmaceuticals Llc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A